Thinking of Buying Boston Properties (BXP)? Here's What You Need to Know.

Shares of Real Estate sector company Boston Properties moved -2.5% today, and are now trading at a price of $53.72. The large-cap stock's daily volume was 312,988 compared to its average volume of 1,530,578. The S&P 500 index returned a -0.0% performance.

BXP (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. The company is based in Boston and has 780 full time employees. Its market capitalization is $8,430,816,768. Boston Properties currently offers its equity investors a dividend that yields 7.1% per year.

16 analysts are following Boston Properties and have set target prices ranging from $52.0 to $80.0 per share. On average, they have given the company a rating of hold. At today's prices, BXP is trading -16.71% away from its average analyst target price of $64.5 per share.

Over the last year, BXP shares have gone down by -23.0%, which represents a difference of -37.0% when compared to the S&P 500. The stock's 52 week high is $79.42 per share and its 52 week low is $46.18. With average free cash flows of $505.48 Million that have been growing at an average rate of 7.1% over the last 6 years, Boston Properties declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 1,278,943 592,438 686,505 1912.6
2022 1,282,399 1,320,273 -37,874 -106.12
2021 1,133,227 513,878 619,349 -8.15
2020 1,156,840 482,507 674,333 6.18
2019 1,181,165 546,060 635,105 39.44
2018 1,150,245 694,791 455,454
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.